APA (7th ed.) Citation

Yedlapudi, D., Xu, L., Luo, D., Marsh, G. B., Todi, S. V., & Dutta, A. K. (2019). Targeting alpha synuclein and amyloid beta by a multifunctional, brain-penetrant dopamine D2/D3 agonist D-520: Potential therapeutic application in Parkinson’s disease with dementia. Nature Portfolio.

Chicago Style (17th ed.) Citation

Yedlapudi, Deepthi, Liping Xu, Dan Luo, Gregory B. Marsh, Sokol V. Todi, and Aloke K. Dutta. Targeting Alpha Synuclein and Amyloid Beta by a Multifunctional, Brain-penetrant Dopamine D2/D3 Agonist D-520: Potential Therapeutic Application in Parkinson’s Disease with Dementia. Nature Portfolio, 2019.

MLA (8th ed.) Citation

Yedlapudi, Deepthi, et al. Targeting Alpha Synuclein and Amyloid Beta by a Multifunctional, Brain-penetrant Dopamine D2/D3 Agonist D-520: Potential Therapeutic Application in Parkinson’s Disease with Dementia. Nature Portfolio, 2019.